Join us in Istanbul for two dynamic days of scientific dialogue, networking, and collaboration — bridging disciplines and driving breakthroughs in targeted therapy.
🔹 Prof. Margret Schottelius (CHUV/University of Lausanne, Switzerland) 🔹 Prof. Jayant Khandare (MIT World Peace University, India) 🔹 Prof. Jai Prakash (University of Twente, Netherlands) 🔹 Experts from leading Turkish institutions like Koç University, METU, Acibadem University, Ege University, and+
From nanomedicine to tissue engineering, from medical devices to translational oncology, this year’s sessions will explore how deep science meets real-world impact.
Our program features over 25 distinguished speakers — scientists, clinicians, and medtech leaders — including:
🎯 The Countdown Begins! We are proud to unveil the full speaker lineup for the 3rd Targeted Therapy Technologies Symposium (TTT25) — a two-day gathering of global innovators at the forefront of biomedical science and health technologies.
🎙 Assoc. Dr. Ahmet Katı Omica & University of Health Sciences “Advanced In-Vitro Strategies for Targeted Therapy Development: Prioritizing Ethics and Translational Impact”
🎙 Milad Riazifar Invitrx “Therapeutic Potential of Engineered Extracellular Vesicles with Anti-Senescence Properties”
🧬 Session 6: Medical Technologies in Translation at the 3rd Targeted Therapy Technologies Symposium (TTT25) features groundbreaking work at the intersection of biomedical engineering, diagnostics, implants, and therapeutic nanotechnologies.
This session brings together outstanding scientists developing novel nanoscale solutions in cancer treatment and gene therapy:
🎙 Prof. Jai Prakash University of Twente, Netherlands “Reprogramming the Tumor Microenvironment: Novel Targeting Strategies for Improved Oncologic Outcomes”
🧪 Session 5: Nanomedicine at the 3rd Targeted Therapy Technologies Symposium (TTT25) will spotlight cutting-edge research in nanoparticle-mediated drug delivery, gene targeting, tumor microenvironments, and photothermal agents.
🎙 Assoc. Prof. Aylin Şendemir Ege University, Türkiye “A Tissue Engineered In-Vitro Blood-Brain Barrier Model as a Tool for Testing of Targeted Delivery to Brain”
🧬 Session 4: Tissue Engineering at the 3rd Targeted Therapy Technologies Symposium (TTT25) will dive into cutting-edge innovations in biomaterials, 3D/4D printing, and tissue models for translational therapies. This session brings together a stellar lineup of speakers regenerative technologies:
